Join
Live feed
·
INSIDERFilingvia Quantisnow
Verve Therapeutics Inc. logo

Chief Financial Officer Dorval Allison converted options into 1,875 shares and sold $3,130 worth of shares (555 units at $5.64), increasing direct ownership by 33% to 5,380 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VERV (Verve Therapeutics Inc.) and more on Quantisnow.